[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"q-nurse-109-1-basic-medicine-052":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":23},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":11},"nurse-109-1-基礎醫學-052","nurse-109-1-basic-medicine-052",109,1,52,"下列何種藥物可抑制 tumor tyrosine kinase 活性，因而可用於 chronic myeloid leukemia 及 gastrointestinal stromal tumor？",{"A":15,"B":16,"C":17,"D":18},"Irinotecan","Etoposide","Palcitaxel","Imatinib","D",null,[],"本題考點是酪胺酸激酶抑制劑在標靶治療的應用。Imatinib 抑制 BCR-ABL 及 c-KIT 等酪胺酸激酶活性，用於慢性骨髓性白血病（CML，BCR-ABL 陽性）與胃腸道基質瘤（GIST，c-KIT 突變），故選 D。(A) Irinotecan 為拓樸異構酶 I 抑制劑，非酪胺酸激酶抑制劑。(B) Etoposide 為拓樸異構酶 II 抑制劑，作用機轉不同。(C) Paclitaxel（題目拼作 Palcitaxel）為紫杉醇類、穩定微管抑制細胞分裂，非酪胺酸激酶抑制劑。故抑制酪胺酸激酶者為 Imatinib，答案為 D。",[24,28,32,36,40,44],{"webId":25,"stem":26,"number":11,"year":27,"session":11},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",106,{"webId":29,"stem":30,"number":31,"year":27,"session":11},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":33,"stem":34,"number":35,"year":27,"session":11},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",3,{"webId":37,"stem":38,"number":39,"year":27,"session":11},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":41,"stem":42,"number":43,"year":27,"session":11},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":45,"stem":46,"number":47,"year":27,"session":11},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840746314]